View source for 18217206. FAST DIAGNOSIS AND PERSONALIZED TREATMENTS FOR ACNE simplified abstract (The Regents of the University of California)

=FAST DIAGNOSIS AND PERSONALIZED TREATMENTS FOR ACNE=


==Organization Name==

[[:Category:The Regents of the University of California|The Regents of the University of California]]


[[Category:The Regents of the University of California]]

==Inventor(s)==

[[:Category:Huiying Li of Los Angeles CA (US)|Huiying Li of Los Angeles CA (US)]][[Category:Huiying Li of Los Angeles CA (US)]]

[[:Category:Shuta Tomida of Santa Monica CA (US)|Shuta Tomida of Santa Monica CA (US)]][[Category:Shuta Tomida of Santa Monica CA (US)]]

[[:Category:Robert L. Modlin of Sherman Oaks CA (US)|Robert L. Modlin of Sherman Oaks CA (US)]][[Category:Robert L. Modlin of Sherman Oaks CA (US)]]

[[:Category:Jeffery F. Miller of Santa Monica CA (US)|Jeffery F. Miller of Santa Monica CA (US)]][[Category:Jeffery F. Miller of Santa Monica CA (US)]]

[[:Category:Sorel T. Fitz-gibbon of Los Angeles CA (US)|Sorel T. Fitz-gibbon of Los Angeles CA (US)]][[Category:Sorel T. Fitz-gibbon of Los Angeles CA (US)]]

==FAST DIAGNOSIS AND PERSONALIZED TREATMENTS FOR ACNE - A simplified explanation of the abstract==


This abstract first appeared for US patent application 18217206 titled 'FAST DIAGNOSIS AND PERSONALIZED TREATMENTS FOR ACNE

==Simplified Explanation==

The patent application focuses on methods of diagnosing and treating patients with acne by targeting specific receptors (RT4, RT5, RT7, RT8, RT9, RT10) with drugs such as small molecules, antisense molecules, siRNAs, biologics, antibodies, phages, vaccines, or a combination thereof.

* Diagnosing acne based on the presence of specific receptors (RT4, RT5, RT7, RT8, RT9, RT10)
* Treating acne by administering drugs that target the identified receptors

== Potential Applications ==
This technology could be applied in the fields of dermatology, pharmaceuticals, and personalized medicine.

== Problems Solved ==
This technology helps in accurately diagnosing acne and providing targeted treatment options, potentially improving patient outcomes.

== Benefits ==
The benefits of this technology include more effective and personalized treatment for patients with acne, potentially reducing side effects and improving overall treatment success rates.

== Potential Commercial Applications ==
Potential commercial applications include the development of new acne treatments, diagnostic tools, and personalized medicine approaches in the dermatology and pharmaceutical industries.

== Possible Prior Art ==
Prior art may include existing methods of diagnosing and treating acne, such as topical treatments, oral medications, and laser therapies.

== Unanswered Questions ==

=== How does this technology compare to existing acne treatments? ===
Answer: This technology offers a more targeted approach by focusing on specific receptors associated with acne, potentially leading to more effective and personalized treatment options.

=== What are the potential long-term effects of targeting these receptors for acne treatment? ===
Answer: Further research and clinical trials would be needed to determine the long-term effects of targeting these receptors for acne treatment, including any potential side effects or resistance development.


==Original Abstract Submitted==

Methods of diagnosing and treating patients afflicted with acne, including diagnosing one as having acne if the individual possesses RT4, RT5, RT7, RT8, RT9, or RT10. Methods for treating acne include administering an effective amount of a drug specifically targeting RT4, RT5, RT7, RT8, RT9, or RT10, such as small molecules, antisense molecules, siRNAs, biologics, antibodies, phages, vaccines, or combination thereof.



[[Category:C12Q1/689]]
[[Category:A61K35/741]]
[[Category:A61K35/76]]
[[Category:A61K39/02]]
[[Category:A61K39/05]]
[[Category:C12N7/00]]
[[Category:C12Q1/6883]]
[[Category:C12Q1/70]]